The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hadron Therapy Market Research Report 2024

Global Hadron Therapy Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1889371

No of Pages : 84

Synopsis

The global Hadron Therapy market was valued at US$ 1500 million in 2023 and is anticipated to reach US$ 2604.2 million by 2030, witnessing a CAGR of 8.2% during the forecast period 2024-2030.

North American market for Hadron Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Hadron Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Hadron Therapy in Pediatric Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Hadron Therapy include Koninklijke Philips, Advanced Oncotherapy, Varian Medical Systems, Optivus Proton Therapy, Hitachi, Mevion Medical Systems, ProTom International, Mitsubishi Electric and Sumitomo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Hadron Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hadron Therapy.

Report Scope

The Hadron Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hadron Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hadron Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Koninklijke Philips
  • Advanced Oncotherapy
  • Varian Medical Systems
  • Optivus Proton Therapy
  • Hitachi
  • Mevion Medical Systems
  • ProTom International
  • Mitsubishi Electric
  • Sumitomo
  • ProNova Solutions

Segment by Type

  • Electron Beam
  • Proton Beam
  • Neutron Beam
  • Carbon Ion Beam
  • Alpha Particle Beam
  • Beta Particle Beam

Segment by Application

  • Pediatric Cancer
  • Bone and Soft Tissue Cancer
  • Prostate Cancer
  • Lung Cancer
  • Liver Cancer
  • Eye Cancer
  • Head & Neck Cancer
  • Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hadron Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hadron Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Electron Beam
1.2.3 Proton Beam
1.2.4 Neutron Beam
1.2.5 Carbon Ion Beam
1.2.6 Alpha Particle Beam
1.2.7 Beta Particle Beam
1.3 Market by Application
1.3.1 Global Hadron Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pediatric Cancer
1.3.3 Bone and Soft Tissue Cancer
1.3.4 Prostate Cancer
1.3.5 Lung Cancer
1.3.6 Liver Cancer
1.3.7 Eye Cancer
1.3.8 Head & Neck Cancer
1.3.9 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hadron Therapy Market Perspective (2019-2030)
2.2 Hadron Therapy Growth Trends by Region
2.2.1 Global Hadron Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hadron Therapy Historic Market Size by Region (2019-2024)
2.2.3 Hadron Therapy Forecasted Market Size by Region (2025-2030)
2.3 Hadron Therapy Market Dynamics
2.3.1 Hadron Therapy Industry Trends
2.3.2 Hadron Therapy Market Drivers
2.3.3 Hadron Therapy Market Challenges
2.3.4 Hadron Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hadron Therapy Players by Revenue
3.1.1 Global Top Hadron Therapy Players by Revenue (2019-2024)
3.1.2 Global Hadron Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Hadron Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hadron Therapy Revenue
3.4 Global Hadron Therapy Market Concentration Ratio
3.4.1 Global Hadron Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hadron Therapy Revenue in 2023
3.5 Hadron Therapy Key Players Head office and Area Served
3.6 Key Players Hadron Therapy Product Solution and Service
3.7 Date of Enter into Hadron Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hadron Therapy Breakdown Data by Type
4.1 Global Hadron Therapy Historic Market Size by Type (2019-2024)
4.2 Global Hadron Therapy Forecasted Market Size by Type (2025-2030)
5 Hadron Therapy Breakdown Data by Application
5.1 Global Hadron Therapy Historic Market Size by Application (2019-2024)
5.2 Global Hadron Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hadron Therapy Market Size (2019-2030)
6.2 North America Hadron Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hadron Therapy Market Size by Country (2019-2024)
6.4 North America Hadron Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hadron Therapy Market Size (2019-2030)
7.2 Europe Hadron Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hadron Therapy Market Size by Country (2019-2024)
7.4 Europe Hadron Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hadron Therapy Market Size (2019-2030)
8.2 Asia-Pacific Hadron Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hadron Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Hadron Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hadron Therapy Market Size (2019-2030)
9.2 Latin America Hadron Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hadron Therapy Market Size by Country (2019-2024)
9.4 Latin America Hadron Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hadron Therapy Market Size (2019-2030)
10.2 Middle East & Africa Hadron Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hadron Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Hadron Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Koninklijke Philips
11.1.1 Koninklijke Philips Company Detail
11.1.2 Koninklijke Philips Business Overview
11.1.3 Koninklijke Philips Hadron Therapy Introduction
11.1.4 Koninklijke Philips Revenue in Hadron Therapy Business (2019-2024)
11.1.5 Koninklijke Philips Recent Development
11.2 Advanced Oncotherapy
11.2.1 Advanced Oncotherapy Company Detail
11.2.2 Advanced Oncotherapy Business Overview
11.2.3 Advanced Oncotherapy Hadron Therapy Introduction
11.2.4 Advanced Oncotherapy Revenue in Hadron Therapy Business (2019-2024)
11.2.5 Advanced Oncotherapy Recent Development
11.3 Varian Medical Systems
11.3.1 Varian Medical Systems Company Detail
11.3.2 Varian Medical Systems Business Overview
11.3.3 Varian Medical Systems Hadron Therapy Introduction
11.3.4 Varian Medical Systems Revenue in Hadron Therapy Business (2019-2024)
11.3.5 Varian Medical Systems Recent Development
11.4 Optivus Proton Therapy
11.4.1 Optivus Proton Therapy Company Detail
11.4.2 Optivus Proton Therapy Business Overview
11.4.3 Optivus Proton Therapy Hadron Therapy Introduction
11.4.4 Optivus Proton Therapy Revenue in Hadron Therapy Business (2019-2024)
11.4.5 Optivus Proton Therapy Recent Development
11.5 Hitachi
11.5.1 Hitachi Company Detail
11.5.2 Hitachi Business Overview
11.5.3 Hitachi Hadron Therapy Introduction
11.5.4 Hitachi Revenue in Hadron Therapy Business (2019-2024)
11.5.5 Hitachi Recent Development
11.6 Mevion Medical Systems
11.6.1 Mevion Medical Systems Company Detail
11.6.2 Mevion Medical Systems Business Overview
11.6.3 Mevion Medical Systems Hadron Therapy Introduction
11.6.4 Mevion Medical Systems Revenue in Hadron Therapy Business (2019-2024)
11.6.5 Mevion Medical Systems Recent Development
11.7 ProTom International
11.7.1 ProTom International Company Detail
11.7.2 ProTom International Business Overview
11.7.3 ProTom International Hadron Therapy Introduction
11.7.4 ProTom International Revenue in Hadron Therapy Business (2019-2024)
11.7.5 ProTom International Recent Development
11.8 Mitsubishi Electric
11.8.1 Mitsubishi Electric Company Detail
11.8.2 Mitsubishi Electric Business Overview
11.8.3 Mitsubishi Electric Hadron Therapy Introduction
11.8.4 Mitsubishi Electric Revenue in Hadron Therapy Business (2019-2024)
11.8.5 Mitsubishi Electric Recent Development
11.9 Sumitomo
11.9.1 Sumitomo Company Detail
11.9.2 Sumitomo Business Overview
11.9.3 Sumitomo Hadron Therapy Introduction
11.9.4 Sumitomo Revenue in Hadron Therapy Business (2019-2024)
11.9.5 Sumitomo Recent Development
11.10 ProNova Solutions
11.10.1 ProNova Solutions Company Detail
11.10.2 ProNova Solutions Business Overview
11.10.3 ProNova Solutions Hadron Therapy Introduction
11.10.4 ProNova Solutions Revenue in Hadron Therapy Business (2019-2024)
11.10.5 ProNova Solutions Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’